Directorate Change

16 March 2015

Phorm Corporation Limited

("Phorm" or the "Company")

Directorate Change

Phorm (AIM: PHRM), a leading internet personalisation technologycompany, announces that Mr Mark Schneider has resigned as a Non-Executive Director of the Company with immediate effect to pursue his other business interests.

Accordingly, the Board will seek to identify and recruit an appropriate replacement non-executive director in due course.

Kent Ertugrul, Chairman and CEO of Phorm, commented:

"Mark made an outstanding contribution during his time as a non-executive director of Phorm. His considerable experience has been a real asset to our business and, on behalf of the Company, we wish him all the best for the future."

Mark Schneider commented:

"I have greatly enjoyed helping Phorm develop and scale its business into new markets and wish the business continued success."

-Ends-

Forfurther information please contact: Phorm Corporation Limited

Andy Croxson (analysts and investors) +44 (0) 203 397 6001

UK Investors

Mirabaud Securities LLP (Broker) +44 (0) 20 7321 2508

Jason Woollard Peter Krens

Strand Hanson Limited (Nominated Adviser) +44 (0) 20 7409 3494

James Harris MatthewChandler James Dance

US Investors

Lippert Heilshorn and Associates (InvestorRelations) +1 212 838 3777

John Heilshorn

About Phorm

Phorm is a global personalisation technology company that makes content and advertising more relevant to the consumer.

Phorm's innovative platform preserves user privacy and deliversa more interesting online experience.

Phorm's industry leading technology enables its Internet Service Provider ("ISP") partnersto offer a new type of online 

advertising platform and a free consumerinternet content feature, ensuring more relevant advertisements and personalised content for opted-inusers.

Phorm's advertising platform revolutionises current standards of online privacy,fully protecting the identityof consumers. 

Phorm'spartners include leading ISPs, Publishers, Advertising Networks and Advertisers.

Phorm,under a predecessor holding company, was admitted to the  AIM marketof the London Stock Exchange in 2004.

For more information, please visit: www.phorm.com